 European
Journal of Gynaecological Oncology - Vol. XXV, n. 1, 2004 |
|
| CONTENTS |
|
| EDITORIAL CORNER |
|
| The twenty-fifth birthday of our Journal |
5 |
A. Onnis - Montréal, CANADA
The foundation and the life of the Journal (the second in this field
all over the world) is remembered with pride. |
|
| |
|
| DISTINGUISHED EXPERT SERIES |
|
| Skin flaps for the Gynaecologist |
7 |
H.H. Allen - London, CANADA
Skin flaps are becoming more frequently indicated in gynecologic surgical
practice, especially in oncologic surgery. It is imperative that the
gynecologic surgeon of today be well informed in the many physiologic
processes of wound healing, also those factors that delay and those
that promote wound healing. Knowledge of the detailed anatomy of the
abdomen, pelvis, vulva, peritoneum and ano-rectal area is essential. |
|
| |
|
| BRIDGING THE GAP |
|
| Evaluation of DNA methylation in the human
genome: Why examine it and what method to use |
19 |
J.P. Geisler, K.J. Manahan, H.E. Geisler - Iowa and Indiana, USA
DNA methylation may cause absence of gene expression. Multiple methods
exist for studying this epigenetic cause of gene dys-function. These
methods are discussed. |
|
| |
|
| EDITORIAL ARTICLE |
|
| Gynecologic oncology specialty |
25 |
P. Benedetti-Panici, R. Angioli - Rome, ITALY
The subspecialty of gynaecologic oncology has made many advances over
the last few decades; there have been several changes in the management
of gynaecologic cancers, which have led to improved outcome and well-being
of patients. |
|
| |
|
| ORIGINAL ARTICLES |
|
| Differential expression of CD40 and CD95 in
ovarian carcinoma |
27 |
G. Ciaravino, M. Bhat, C.A. Manbeian, N.N.H. Teng - Stanford, CA
(USA)
Expression and function of two proteins associated with signaling
pathways that control cell death are evaluated in ovarian car-cinoma. |
|
| Effect of cis-diammine dichloroplatinum on
vascular endothelial growth factor expression in uterine cervical
carcinoma |
33 |
Y. Miyahara, S. Yoshida, S. Motoyama, Y. Hamana, T. Maruo - Kobe,
JAPAN
Our findings indicate that CDDP-induced increases in VEGF production
by cervical carcinoma cells may stimulate angiogenesis in tumor lesions. |
|
| Treatment policy of neuroendocrine small cell
cancer of the cervix |
40 |
X.-B. Trinh, J.J. Bogers, E.A. Van Marck, W.A.A. Tjalma - Edegem,
BELGIUM
A case of an IB1 neuroendocrine small cell cancer of the cervix which
was successfully treated with a multimodal approach is discussed. |
|
| Changes in vascular endothelial growth factor
(VEGF) after chemoendocrine therapy in breast cancer |
45 |
N. Fersis, B. Smyczek-Gargya, S. Armeanu, E. Gagulic, L. Pantic,
K. Relakis, M. Friedrich, D. Wallwiener -Tübingen
and Lübeck, GERMANY
Only high concentrations of chemotherapeutic drugs lead to suppression
of VEGF and angiopoietin-1 gene expression. |
|
| Use of the nested reverse transcription-polymerase
chain reaction for the detection of human papillo-mavirus 16 E6 transcriptional
activity in cervical cancer: A technical perspective |
51 |
M. Moodley, J. Moodley, C.S. Herrington, S. Sewart, R. Chetty -
Durban, SOUTH AFRICA
Nested RT-PCR is superior to conventional RT-PCR to evaluate HPV-related
cervical carcinogenesis. |
|
| Quantitative study on the correlation between
p53 gene mutation and its expression in endometrial carcino-ma cell
lines |
55 |
Y. Kamata, J. Watanabe, H. Hata, M. Hamano, H. Kuramoto - Tokyo,
JAPAN
The amount of p53 protein was investigated by immunocytochemistry
and immunoblotting, and compared with p53 gene mutation in endometrial
carcinoma cell lines. |
|
| Is direct large loop electric excision for
the transformation zone reasonable in the investigation of high-grade
squamous intraepithelial lesions in cervical smears? |
61 |
K.Y. Ng, C.K. Chang, J. Chen, P.H. Wang, S.W. Teng - Taipei, TAIWAN
Applying direct large loop electric excision to the transformation
zone (LLETZ) for the management of cervical high grade intraepithelial
lesions might be a reasonable choice because it has good diagnostic
accuracy with minimal morbidity and an acceptable low over-treatment
rate. |
|
| Taxanes in the first-line chemotherapy of metastatic
breast cancer: Review |
66 |
M. Friedrich, D. Diesing, C. Villena-Heinsen, R. Felberbaum, H.C.
Kolberg, K. Diedrich - Baden and
Lübeck, GERMANY
Taxanes belong to the most effective agents in the treatment of advanced
and non-hormone responsive breast cancer. Thus, the combination of
anthracyclines (adriamycin, doxorubicin) and taxanes (docetaxel, paclitaxel)
is a promising tool in the treat-ment of metastatic breast cancer. |
|
| Neuroectodermal immunophenotype in uterine
malignant mullerian tumors (MMT): Comparative immunohistochemical
analysis with embryonal uterine development |
71 |
A. Karseladze, A. Perevoshchikov, S. Navarro, A. Llombart-Bosch
- Moscow, RUSSIA and Valencia, SPAIN
Both components of uterine MMT display coexpression of different types
of antigens including those of neural differentiation. This phenomen
is a recapitulation of the immunophenotype of the embryonal uterus. |
|
| The relationship between expression of p53/bcl-2
and clinicopathological criteria in endometrioid adeno-carcinomas
of the endometrium |
79 |
I. Sari, A. Gocmen, M. Bitiren, E.A. Cakmak - Gaziantep, TURKEY
A decrease in bcl-2 reactivity and an increase in p53 positive staining
was observed as the histological differentiation worsened. |
|
| Early stage cervical cancer with negative pelvic
lymph nodes: Pattern of failure and complication follow-ing radical
hysterectomy and adjuvant radiotherapy |
81 |
S.W. Chen, J.A. Liang, S.N. Yang, F.J. Lin - Taichung, TAIWAN
For patients with lymph node negative cervical cancer following radical
hysterectomy, adjuvant lower pelvic radiation appears to be effective
for pelvic control. It is also imperative to intensify the strategies
of adjuvant therapy for some subgroups of patients. |
|
| What is the number of lymph nodes required
for an “adequate” pelvic lymphadenectomy? |
87 |
H.W. Nijman, M. Khalifa, A. Covens - Groningen, THE NETHERLANDS
The minimum number of pelvic lymph nodes (PLN) identified at a PLND
to be defined as adequate is five or six lymph nodes. |
|
| Protocol combining GnRH agonists and GnRH antagonists
for rapid suppression and prevention of gonadal damage during cytotoxic
therapy |
90 |
T. Mardesic, M. Snajderova, L. Sramkova, P. Keslova, P. Sedlacek,
J. Stary - Prague, CZECH REPUBLIC
The combination of GnRH-agonist and GnRH-antagonist enables a quick
and cost-effective suppression of the pituitary-gonadal axis to be
achieved. |
|
| Attitudes toward preventive oophorectomy among
BRCA1 mutation carriers in Poland |
93 |
J. Menkiszak, I. Rzepka-Górska, B. Górski, J. Gronwald,
T. Byrski, T. Huzarski, A. Jakubowska,
K.A. Metcalfe, S.A. Narod, J. Lubin´ski - Szczecin, POLAND
In this study the acceptance of a prophylactic oophorectomy among
Polish BRCA1 mutation carriers was evaluated. |
|
| The incidence of female genital tumors in the
province of Sassari in the period 1992-2000 |
96 |
A. Cossu, M. Budroni, G. Capobianco, D. Pirino, G. Palmieri, S.
Dessole, F. Tanda, R. Cesaraccio,
P.L. Cherchi - Sassari, ITALY
The incidence of female genital tumors in the province of Sassari
in the period 1992-2000 is reported. |
|
| Clinical features of familial ovarian cancer
lacking mutations in BRCA1 or BRCA2 |
99 |
J. Menkiszak, J. Gronwald, B. Górski, T. Byrski, T. Huzarski,
A. Jakubowska, M. Foszczyn´ska-Kloda,
M. Brzosko, J. Flicin´ski, I. Rzepka-Górska, S.A. Narod
- Szczecin, POLAND
In this study clinical and pathologic features of ovarian cancers
were identified in patients with a strong familial history of breast
or ovarian cancer but no mutation in the BRCA1/2 was detected. |
|
| The expression of epithelial specific antigen
in cervical intraepithelial neoplasia and adenocarcinoma |
101 |
S. Markaki, D. Lazaris, I. Papaspirou, V. Paulou - Athens, GREECE
Forty cases of glandular lesions of the cervix were studied immunohistochemically
in order to examine the localization of epithelial specific antigen
(ESA) and to prove that ESA is a useful marker regarding the diagnosis
of glandular intraepithelial neoplasia. |
|
| Preoperative brachytherapy in endometrial cancer
- proposal of a new clinical protocol |
104 |
J. Sobotkowski, M. Grzelak, A. Pietraszek, M. Wieczorek - Lodz,
POLAND
Preoperative brachytherapy in endometrial cancer is described and
diagnosis and treatment proposals are shown. Usage of this method
may avoid teleradiotherapy in some patients, is safe in experienced
hands but needs further investigation and discus-sion. |
|
 |
|
| CASE REPORTS |
|
| SIADH associated with ovarian immature teratoma:
a case report |
107 |
C.M. Lam, V. Shun-yin Yu - Hong Kong, SAR (CHINA)
A case of confirmed SIADH, associated with ovarian immature teratoma,
which subsided after the curative surgery is reported. |
|
| Large cell neuroendocrine carcinoma of the
uterine corpus metastatic to brain and lung: Case report and review
of the literature |
109 |
Y. Erhan, Y. Dikmen, M.S. Yucebilgin, O. Zekioglu, L. Mgoyi, M.C.
Terek - Izmir, TURKEY
A patient with large cell neuroendocrine carcinoma of the uterine
corpus metastatic to the brain and lung is reported. |
|
| Mucinous tumors of the appendix presenting
as primary tumors of the ovary. Report of two cases |
113 |
A. Liapis, E. Michailidis, P. Bakas, A. Kondi-Pafiti, G. Creatasas
- Athens, GREECE
Two cases of mucinous tumors of the appendix presenting as primary
tumors of the ovary are presented. |
|
| Ovarian Sertoli-Leydig cell tumor with coexisting
vaginal angiomyxoma: Case report and review of the literature |
116 |
P. Tampakoudis, M. Zafrakas, E. Kostopoulou, K. Dragoumis, T. Tsalikis,
J. Bontis - Thessaloniki, GREECE
A rare case of an ovarian Sertoli-Leydig cell tumor with a coexisting
vaginal angiomyxoma is presented. |
|
| Diffuse malignant epithelial peritoneal mesothelioma
in pregnancy. A case report and literature review |
119 |
T. Pekin, E. Cos¸ar, N. Dedeog?lu, F. Çakalag?aog?lu,
H. Gökaslan, Z. Kavak - Istanbul, TURKEY
Mesothelioma in pregnancy is a rare peritoneal malignancy and is regarded
as a universally fatal cancer with few treatment options. |
|
| Phyllodes tumor of the breast: case series
of 40 patients |
123 |
E. Eroglu, C. Irkkan, F. Eroglu - Isparta, TURKEY
Cystosarcoma phyllodes is a rare, uncommon fibroepithelial tumor of
the breast. The clinical situation in relation to the histopathologic
findings is analyzed. Forty types of surgery, recurrences, histopathologic
diagnoses and follow-up of patients were studied retrospectively. |
|
| Acute myeloblastic leukemia in pregnancy: a
case report and review of the literature |
126 |
M.S. Yucebilgin, S. Cagirgan, A. Donmez, E. Ozkinay, F. Akercan,
L. Mgoyi, F. Vural - Izmir, TURKEY
A case of acute myelocytic leukemia diagnosed during the third trimester
and treated with chemotherapeutic agents before delivery is reported. |
|
| |
|